Capital World Investors Tg Therapeutics, Inc. Transaction History

Capital World Investors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.81 - $20.45 $32.6 Million - $85.3 Million	-4,172,153 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $334 - $781	22 Added 0.0%	4,172,153 $79.3 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $18,055 - $33,533	829 Added 0.02%	4,172,131 $139 Million
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $33.1 Million - $49.8 Million	1,017,359 Added 32.26%	4,171,302 $162 Million
Q1 2021 May 14, 2021	BUY	$41.61 - $54.3 $95.9 Million - $125 Million	2,303,943 Added 271.05%	3,153,943 $152 Million
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $21.5 Million - $46.7 Million	850,000 New	850,000 $44.2 Million

336

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.